Current use of opioids in anaesthesia is reviewed with particular emphasis on the use of opioids in anaesthetic doses, techniques that recently have become popular in cardiovascular anaesthesia. A major benefit of opioid anaesthesia (particularly fentanyl) is the cardiovascular stability which obtains during induction and throughout operation, even in patients with severely impaired cardiac function. Anaesthetic doses of morphine are associated with a higher incidence of cardiovascular disturbances and other problems. Pethidine is unsuitable for cardiovascular surgery because of severe haemodynamic disturbances when high doses are given. Sufentanil and alfentanil may prove more suitable alternatives. High doses of opioids can reduce or prevent hormonal and metabolic responses to the stress of surgery. Even very large doses of fentanyl or its new analogues do not prevent marked increases in plasma catecholamine concentrations in response to cardiopulmonary bypass. The reduction in hormonal and metabolic stress response does not appear to continue postoperatively.
1803 and introduction of the syringe and hollow needle in 1853 ihat a narcotic analgesic was administered parenterally in known amounts. 7 Morphine was first used as an intramuscular preoperative premedicant before or intraoperative supplement during inhalation anaesthesia in the middle to late decades of the nineteenth century. Late in the 19th century large amounts of morphine (1 to 2 mg/kg) plus scopolamine (1 to 3 mg170 kg) were administered in divided doses intravenously, intramuscularly, or both, as a complete anaesthetic. 8 ,9 Although initially popular, this technique rapidly fell into disfavour because of an alarming increase in operative morbidity and mortality.7.1O For the next thirty to forty years, anaesthesiologists rarely used narcotic analgesics intraoperatively. 7 Three important events that led to the reintroduction of opioids into operative anaesthetic practice included the introduction of the ultra-short-acting barbiturates as intravenous anaesthetics, popularisation of the concept of 'balanced anaesthesia', and the synthesis and use of pethidine (meperidine) for anaesthesia with nitrous oxide (N 2 0). 7.11,12 Many variations of the 'nitrous oxide-narcotic' technique became popular. At first, thiopentone (as an induction agent and/or as an additional supplement during maintenance), d-tubocurarine (for muscular relaxation) and opioids such as morphine, pethidine, or alphaprodine were used for nitrous oxide-narcotic anaesthesia. After the introduction of innovarnitrous oxide anaesthesia I] (innovar consists of droperidol, a buterophenone, and fentanyl), a variety of intravenous supplements were employed (including hypnotics, sedatives, tranquillisers, and additional analgesics). 14 18 These techniques were often termed balanced anaesthesia, presumably because each intravenously administered compound was selected and used for a specific purpose, such as analgesia, amnesia, muscle relaxation, or abolition of autonomic reflexes. More recently, opioids as well as other analgesics (synthetic agonist/antagonists) and hypnotics, are being administered intravenously during anaesthesia with potent inhaled anaesthetics. 19 This practice is based on the belief that many of these drugs reduce the concentrations of inhaled anaesthetics required for anaesthesia and thus result in less depression of the cardiovascular and other organ systems. 20, 21 De Castr0 22 and Lowenstein et al. 2 ] reintroduced the concept that high doses of opioids could produce 'complete' anaesthesia. They administered fentanyl or morphine intravenously until consciousness was lost and then controlled ventilation with a high inspired concentration of oxygen. Morphine, 0.5 to 1.0 mg/kg, administered intravenously to patients while they breathed 100070 oxygen did not alter the cardiovascular dynamics in patients who did not have cardiac disease and in many cases improved the cardiovascular status of those with significant valvular disease. These reports led to many additional studies evaluating morphine and other opioids as the sole anaesthetic for patients with little cardiovascular reserve undergoing major surgery. [24] [25] [26] [27] Unfortunately, problems with incomplete amnesia,28,29 histamine release,29,]0 prolonged postoperative respiratory depression,]I.]) increased blood volume requirements secondary to marked Anaesthesia and Intensive Care, Vol. /5, l"'o. /, February, 1987 venovasod i lat ion, 26 and hypertension 25 decreased the popularity of morphine as a 'complete' anaesthetic.
In contrast the synthetic opioid fentanyl has become popular as a component of balanced (nitrous oxide-narcotic) anaesthesia,13.27 as a supplement when using an inhaled anaesthetic,19 but also in larger (anaesthetic) doses (50 to ISO J1g/kg) as a primary or complete anaesthetic. 2 ,],29 Unfortunately, large doses of fentanyl also cause significant postoperative respiratory depression,2,] which minimises their use in healthy patients undergoing more routine operations. Nevertheless, as with anaesthetic doses of morphine, large intravenous doses of fentanyl can produce complete anaesthesia without depressing cardiovascular function and are ideal for patients who have little or no cardiovascular reserve. In addition, fentanyloxygen anaesthesia produces less prolonged postoperative respiratory depression, greater cardiovascular stability, little or no histamine release, and no venovasodilation, as compared with morphine. 2 
.3.29-]]
Despite some problems (e.g. muscle rigidity, incomplete anaesthesia), opioids will probably remain popular as anaesthetic supplements and as complete anaesthetics in the future because of their minimal effect on most organ systems. 2 -6 Analgesia-amnesia-anaesthesia
The reintroduction in 1969 of morphine plus oxygen as an anaesthetic technique for patients with heart disease was based on the premise that large doses of morphine could produce anaesthesia without significant changes in cardiovascular dynamics. The problems encountered with morphine also stimulated the evaluation of other more potent opioids such as fentanyl, sufentanil, and alfentanil and other synthetic opioids as anaesthetics or principal components of the narcotic-based anaesthetic state. Many of these studies demonstrated that as potency increased, undesirable side effects of narcotic analgesics decreased. Opioids, particularly pure J1-receptor stimulating agonists, produce unconsciousness and anaesthesia in humans when given in high enough doses. Yet some investigators still believe that opioids -all of them -should not be expected to produce unconsciousness and anaesthesia. I ,34 Reports demonstrating that fentanyl is only able to decrease the minimal alveolar concentration (MAC) of enflurane approximately 65OJo in dogs, and similar studies in rats and experimental animals, are often submitted as evidence in support of this position. 35 ,36 Unfortunately, equi-effective doses of narcotic analgesics and many other intravenous sedative-hypnotics and anaesthetics vary enormously in different species. 37 ,38 Dosage requirements for fentanyl are 30 times higher in dogs than in humans. 38 Furthermore, metabolic processing of opioids is often dramatically different in the dog and other animals than in humans. Clearly, data obtained from animals using doses of opioids and infusion schemes similar to those used in the clinical setting are of questionable relevance when applied to humans.
Incomplete amnesia remains an occasional problem with low and high doses of opioidbased anaesthesia. In virtually all cases, recall of pain is rare. A most likely reason for awareness and/or inadequate anaesthesia during narcotic analgesic-based anaesthesia is the difficulty of reliably predicting the appropriate dose of an opioid in any individual patient. Generally, healthier patients, that is, American Society of Anesthesiologists (ASA) class I or Il, with normal or high cardiac outputs prior to anaesthesia require larger doses of narcotics for anaesthesia than do patients who have serious metabolic disease, cardiovascular limitations, or reduced cardiac output. 2, 3, 32, 40 Older patients experience higher blood and presumably brain concentrations of opioids than do younger patients. Most likely this explains the ease with which they are rendered anaesthetic with opioids 40 (Table 1) . Patients' habits (e.g. smoking, alcohol consumption) may also influence anaesthetic requirements. 41 Undoubtedly, differences in plasma protein-binding, fat solubility, hepatic metabolism, renal excretion, and regional perfusion influence requirements for opioids as well. How and why all these factors influence opioid and analgesics and anaesthetic requirements in humans is unknown. However, if data obtained in rat receptor-binding studies are applicable, the answer may lie in determining and ensuring that the percentage of CNS opioid-receptor occupation necessary for anaesthesia is achieved in every patient. 42 This will undoubtedly be difficult for many reasons, not the least of which relates to variability of opioid requirements in the same individual. Indeed, acute tolerance, as seen with barbiturates seems to occur with opioids 43 (Bailey et al., unpublished data) . Awakening or absence of analgesia can take place at higher plasma opioid levels than are associated with initial loss of consciousness or onset of analgesia. 43   TABLE 1 Unconsciousness as a function of age in 72 When an opioid is used in large doses as a complete anaesthetic or with supplements, such as nitrous oxide or other intravenous compounds, there are few reliable, measurable clinical indications of amnesia. This too contributes to the problem of inadequate anaesthesia. Profound analgesia and apnoea can easily be achieved with opioids without producing anaesthesia. 26 While administration of supplements (nitrous oxide, diazepam, droperidol) or of larger doses of narcotic anaesthetics will increase the likelihood of amnesia, they do not guarantee it. 40 Furthermore, undesirable side effects such as prolonged postoperative respiratory depression and cardiovascular depression are frequent after administration of some supplements. 14, 15, 44 The reported frequency of awareness with fentanyl anaesthesia in human subjects is comparable to that with inhaled anaesthetics. 45 • 5o Nonetheless, concern about the occurrence of awareness remains legitimat~. Hypertension and traumatic neurosis (consisting of repetitive nightmares, anxiety, preoccupation with death, and patient resistance to talking about recall) can occur .-18.51 A wareness associated wi th anaesthesia is best dealt with by preoperatively informing patients of its possibility and by frank and open discussion of such an episode postoperatively. Direct explanation may be most helpful to a reluctant and fearful patient. 51
Cardiovascular actions
Although hypotension, hypertension, bradycardia, and numerous other cardiovascular problems were reported after morphine administration, those side-effects seem to occur less frequently when fentanyl is used. 2 . 23 The newer, more potent opioid, sufentanil, also usually produces minimal changes in cardiovascular dynamics. 52.53 In fact, administration of morphine, 1.0 mg/kg IV, usually does not cause significant circulatory changes in patients with or without cardiac disease. 23 In patients with aortic valvular disease, stroke volume and cardiac output may be increased after morphine administration, probably because the compound does not result in myocardial depression but does decrease systemic vascular resistance, at least transiently.23.54. 55 Vasko and co-workers 56 found that morphine has a significant positive inotropic effect that is dependent on endogenous catecholamine release in dogs. This action is inhibited by (3-adrenergic blocking agents or by previous adrenalectomy. Morphine has also been found to increase blood and urine catecholamine concentrations in a dose-dependent manner in patients with cardiac disease. 57 . 59 Although large doses (0.5 to 30 mg/kg) of fentanyl produce significant increases in plasma catecholamines in dogs,60 anaesthetic doses of fentanyl (24 to 75 J..Ig/kg) decrease rather than increase plasma catecholamines and cortisol concentrations in humans. 61 The effect of fentanyl on plasma catecholamines may be dose dependent. Hicks et al. 62 still others a myocardial depression-sparing action of fentanyl during halothane and enflurane anaesthesia. 20 ,21 Despite these minimal cardiovascular effects of opioids, significant hypotension, hypertension, and cardiac dysrhythmias have been reported after the administration of virtually all opioid compounds in some patients. Therefore, certain precautions should be observed during the induction and maintenance of anaesthesia with morphine and other opioids. Several mechanisms, including vagal-induced bradycardia, venous and arterial vasodilation, and splanchnic sequestration of blood, may explain some of the hypotension observed after morphine anaesthesia. Rate of morphine infusion also appears to be important in producing and/or avoiding hypotension. Hypotension is not uncommon when the infusion rate is 10 mg/min but is rare when it is < 5 mg/min. 67 Rate of infusion seems to have less of an effect on blood pressure after fentanyl and sufentanil but may be important with alfentaniL Morphine, 1.0 mg/kg, produced marked increases in plasma histamine in some patients. These changes usually result in an increase in cardiac index and in decreased arterial blood pressure and systemic vascular resistance. 68 Similar cardiovascular changes occur when patients are pretreated with diphenhydramine (a histamine H i-antagonist) or cimetidine (a histamine H 2 -antagonist) before morphine. However, in patients pretreated with both Hi-and H2-antagonists, the cardiovascular responses are significantly attenuated despite comparable increases in plasma histamine concentrations. These data and other reports 69 . 71 strongly suggest that many of the haemodynamic effects of morphine may be caused by histamine and indicate a possible means of preventing these changes. Significant hypotension rarely occurs with high-dose fentanyl anaesthesia, possibly because, unlike morphine, fentanyl does not produce increases in plasma histamine. 68 Sufentanil and alfentanil do not produce changes in plasma histamineY Morphine has been shown to reduce venous and arterial tone both in experimental animals and in human subjects, which results in a decrease in venous return to the heart and may contribute to hypotension. 23 . 26 ,72-77 Arterial dilation occurs sooner and is of shorter duration than venodilation after morphine. 75 ,78 The degree of venodilation is dose-related and necessitates an increase in the volume of blood and/or crystalloid fluids to maintain adequate ventricular filling pressure. 75 Patients anaesthetised with halothane as compared with those anaesthetised with morphine have increased blood requirements during and after operation ( Table 2) . Venodilation and increased blood requirements apparently do not occur with lower doses of morphine «0.5 mg/kg) plus N20.
Although morphine reduces venous return to the heart in the dog by causing hepatic sequestration of plasma, 76,77 there is no evidence that this mechanism is of any significance in humans. Others have suggested that venous vasodilation after large doses of morphine is the primary cause for decreased venous return. 26 ,75,78 This is not caused by the preservatives present in commercial preparations of the drug 78 but may be related to a reflex mechanism(s). Zelis and co-workers 79 found that morphine selectively impairs certain sympathetic reflexes involving peripheral veins. Their data suggested that this response was due to a eNS action of the drug. Vasodilation after morphine may also be due to a direct effect of morphine on vascular smooth muscle. 68 ,72.78 Venoconstriction in response to tilting or inhalation of carbon dioxide is also impaired by morphine. 80 In dogs, hypotension after large doses of morphine (1.0 mg/kg) has been attributed to changes in distribution of blood flow. 81 Although not associated with sustained decreases in cardiac output, blood pressure, or total peripheral resistance, Priano and Vatner 81 found 1.0 and 3.0 mg/kg of morphine produces significant decreases in mesenteric and renal blood flow in dogs.
The hypotension that occurs after morphine is not associated with significant myocardial depression, although in healthy volunteers morphine (2 mg/kg) does cause a prolongation of the pre-ejection period, an estimate of isovolumetric cardiac contractility.82,83 High doses of morphine (3 mg/kg) acutely activate the sympathoadrenal system (while producing peripheral vasodilation).84 These changes could counteract any myocardial depressant effects of the opioid. On the other hand, increases in sympathetic activity could be detrimental in some patients. Indeed, Moffitt et al. 55 showed that 1.0 mg/kg of morphine may not inhibit lactate production and can produce ischaemia with surgical stimulation in patients undergoing coronary artery bypass operations. In summary, hypotension from morphine can be minimised or eliminated by pretreatment with H I -and H2-histamine antagonists, use of a TABLE2 slow drug-infusion rate, volume loading, and/or placement of patients in a Trendelenburg (head-down) position.
Blood requirements during operation and [or the [irst postoperative day in 61 patients anaesthetised with morphine (1-4I11g/kg) plus oxygen or halothane (0.1-1.5%) plus 30% nitrous oxide and oxygen and undergoing aortic valve replacement or coronary artery bypass operation

Perhidine
Hypotension also occurs after the intravenous administration of pethidine. Indeed, pethidine has been studied in isolated cardiac preparations, intact dogs, and human subjects in a variety of experimental conditions by several investigators. 85 . 91 It also causes signi ficant increases of plasma histamine. 70 Most investigations indicate that pethidine decreases myocardial contractilitl l and that, even in low doses (2 to 2.5 mg/kg), causes a significant drop in arterial blood pressure, peripheral resistance, and cardiac output. The latter are often accompanied by tachycardia in intact animals 85 . 87 ,9o and man. 89 ,90 Anaesthetic doses of pethidine (10 mg/kg IV) are associated with marked decreases in cardiac output and frequently cause cardiac arrest in dogs, 85 The cardiovascular depression seen with pethidine in animal experiments appears to be due to peripheral vasodilation and to a decrease in myocardial contractility.85,87,90,91 When equianalgesic doses of pethidine were compared with morphine, pethidine was found to be 20 times more depressant to the contractile element of the isolated cat papillary muscle than was morphine. 91 In contrast to morphine, pethidine administration rarely results in bradycardia but can cause tachycardia. This may be due to its structural similarity to atropine. Because of its more significant cardiovascular actions, pethidine has little value as a 'complete anaesthetic' and may be detrimental to patients who have little cardiovascular reserve, even in small doses.
Fentanyl
Fentanyl, in analgesic (2 to 10 JAg/kg) or anaesthetic (30 to lOO JAg/kg) doses, rarely causes decreases in blood pressure, even in patients with poor left ventricular (LV) fu nction. 2,27 ,62,63,91.92.93 Some in vestiga tors believe that absence of hypotension after fentanyl is related to this opioid's lack of effect on plasma histamine concentrations.
Most evidence indicates that fentanyl produces little or no change in myocardial con tractility ,2,20,63,64,94 although a few workers have reported a negative inotropic effect. 63 The use of adjuvants to supplement opioid anaesthesia results in a higher incidence of hypotension.
Sufentanil
Sufentanil is a new synthetic opioid that is approximately 5 to 10 times more potent that fentanyl, with a therapeutic index (LD50/ED50) approximately lOO times greater than that of the latter (25,000 versus 277) in rats. 99 Sufentanil will likely be used as an anaesthetic supplement and complete anaesthetic. The cardiovascular actions of sufentanil are similar to those of fentanyl. However, sufentanil may be more effective in blocking sympathetic activation during surgical stimulation, especially in patients more susceptible to intraoperative hypertension. Like fentanyl, sufentanil results in no change in plasma histamine concentrations. 33
Alfenranil
Alfentanil is one-fourth as potent as fentanyl. This particularly short-acting agent also has a high therapeutic index (1080) 104 Indeed, hypotension can occur during induction of anaesthesia with alfentanil in ASA class II to IV patients. 104, 105 Modest increases in heart rate and arterial blood pressure have also been reported following anaesthesia with alfentanil in young un premedicated adults. It appears that more experience is necessary before conclusions can be drawn about the value of alfentanil as an induction agent or analgesic supplement. HYPERTENSION 
Morphine
Hypertension during cardiovascular surgery was also a problem in patients anaesthetised with morphine. 25 ,66,106 Arens et al. 25 reported a 36070 incidence of hypertension, defined as a rise in systolic blood pressure to > 200 mmHg or an increase to 60 mmHg above preoperative pressure, in patients undergoing coronary artery surgery with 2 mg/kg of morphine. Hypertension during morphine anaesthesia has been variously attributed to light or inadequate anaesthesia,28 reflex mechanisms,28 stimulation of the renin-angiotensin mechanism,107 and sympathoadrenal activation.84
Fentanyl
With the exception of inadequate anaesthesia,108 the above explanations do not appear to be valid in the case of fentanyl and, to date, the mechanism responsible for hypertension with fentanyl anaesthesia remains unclear despite various suggested explanations. 96 Although hypertension is rare before endotracheal intubation or surgical stimulation with high-dose fentanyl anaesthesia for cardiac surgery, it is the most common cardiovascular disturbance during or after sternotomy and aortic root manipulation. 92,109-11 I The reported incidence of hypertension with fentanyl-based anaesthesia varies widely. Stanley et al. 2 ,3 reported no change in cardiovascular variables following surgical stimulation. Other investigators have reported incidences of hypertension specifically related to sternotomy from 0 to 100070 in patients given fentanyl 50 to 100 J..Ig/kg. 41 ,92,96,108-112 The reason for this variability between investigators is not clear. Possible explanations include the rate of fentanyl administration, the induction and subsequent doses and their time of administration, and the type of muscle relaxant used for endotracheal intubation and the rate of its administration. Other possible factors include the kind and dose of maintenance muscle relaxant, the degree of (3-adrenergic and/or calcium channel blockade present at the time of surgery, preoperative ventricular function, patient habits, and/or the presence or absence of awareness. 41 -48 ,108,1I0-112 In an investigation comparing fentanyl requirements in patients undergoing coronary artery surgery in Salt Lake City, Utah, and Leiden (The Netherlands), it was found that poststernotomy hypertension occurred in only 10070 of patients in Salt Lake City with fentanyl (75 J..Ig/kg) but was present in 80070 of Dutch patients in spite of 121 J..Ig/kg of fentanyl.I08 Higher doses of fentanyl (130 to 140 J..Ig/kg) reduced this incidence of hypertension in Dutch patients. A recent study suggests that these differences in fentanyl requirements between populations may be related to different patient habits. 41 Apparently, a history of smoking plus alcohol and caffeine consumption increases fentanyl requirements for anaesthesia.
Although satisfactory control of haemodynamics can be achieved by increasing the dose of fentanyl,108,1I0 the use of such extremely high doses is inappropriate considering associated problems and the availability of alternative techniques. Doses of fentanyl of 140 J..Ig/kg are likely to result in prolonged respiratory depression during the postoperative period. l08 Satisfactory blood pressure control can be achieved with fentanyl (50 to 120 J..Ig/kg) plus vasodilator therapy. 96,108-110, 113 However, with lower doses of fentanyl (~50 to 120 J..Ig/kg), and no supplements, there may be an increased risk of intraoperative awareness that has never been reported with doses of > 120 J..Ig/kg but has occasionally been reported with lower doses. [48] [49] [50] The total amount of fentanyl used is often limited to 100 J..Ig/kg. When haemodynamic Anaesthesia alld Intensive Care, Vol. 15, No. /, February, 1987 control IS not achieved with this dose, vasodilator therapy is begun with sodium nitroprusside. Other clinicians may supplement anaesthesia with a potent inhaled anaesthetic and/or an intravenous sedative-hypnotic 2 .48 to control episodes of hypertension. Mixing opioids with inhaled anaesthetics decreases stroke volume, cardiac output, and mean arterial blood pressure (MABP) and increases ventricular filling pressure. 19 .114 Yet fentanyl and potent inhaled anaesthetic (enflurane or halothane) can be given together without decreasing myocardial contractility or blood pressure, cardiac output, and stroke volume. 20 . 21 Furthermore, some inhaled anaesthetics (halothane or isoflurane) may be protective to the myocardium during periods of ischaemia.115.116 Nonetheless, the effects of adding inhaled anaesthetics to large doses of fentanyl or other opioids on the myocardial oxygen supply-demand ratio in patients with coronary artery disease are uncertain.
Su/enlanil
Sufentanil may result in a lower incidence of hypertension when used in anaesthetic doses (10 to 20 J.lg/kg) with oxygen for myocardial revascularisation. 112 Sufentanil also decreases the MAC of potent inhaled anaesthetics to a greater degree than has been found with fentanyl in animal subsidies. 35.117 Whether these data have relevance to humans remains to be proved. Nonetheless, significantly lower incidences of hypertension (requiring vasodilation therapy) have been reported with sufentanil as compared with equipotent doses of fentanyl. 53.112 Sufentanil also provides as much 118.119 cardiovascular stability as fentanyl (or possibly greater) when employed in a balanced anaesthetic technique.52.120
AI/enlanil
More experience is necessary before conclusions can be drawn concerning hypertension in association with alfentanil. However, it is already apparent that hypertension during induction with an alfentanil-based anaesthetic are due to stimulation of the central vagal nucleus in the medulla, since they can be blocked with bilateral vagal ligation or the use of atropine or similar belladonna-like drugs in experimental animals. 22 Fentanyl-induced bradycardia is more marked in anaesthetised than in conscious dogs or human subjects. I 22.123 When used for induction of anaesthesia, there is a higher incidence of bradycardia when patients or dogs breathe pure oxygen than when nitrous oxide is used with oxygen. 124.125 This may be due to the increase in sympathetic nervous system activity associated with nitrous oxide anaesthesia. 126.127 Second and subsequent doses of fentanyl cause less bradycardia than do initial doses. 6 0,124 Infusions in dogs decrease heart rate within the first 50 J.lg/kg of fentanyl. 124 Administration of additional fentanyl (up to 2 mg/kg) is required to duplicate the initial percentage decrease in heart rate in dogs. 60 The degree of bradycardia after infusion of opioids may, to some extent, be dose-related,60·122.128 although an equally important factor is the speed of injection. While a well-controlled experimental investigation has not been published, clinical experience in human subjects and animals studies with numerous species I24 ,128.129 suggest that bradycardia can be minimised by slow administration of potent opioids. Premedication with atropine or glycopyrrolate can minimise bradycardia induced by morphine, fentanyl, or other highly potent opioids but does not always eliminate it. 2.3.40.60,124.129-131 Atropine is also usually effective in treating opioid-induced bradycardia, but anecdotal reports suggest that even large doses (I to 2 mg) are occasionally ineffective. Prior administration of small to moderate doses of intravenous pancuronium (0.5 to 2.0 mg) before induction of anaesthesia with fentanyl or other potent narcotics attenuates bradycardia.96.132.133
The mechanism of fentanyl-induced bradycardia is not completely understood, although stimulation of the central vagal nucleus is likely. 122 Bradycardia is almost totally prevented by bilateral vagotomyl22 or pharmacologic vagal block with atropine. 124 Blockade of sympathetic chronotropic action may also have a minor role. l22 Similar mechanisms have been proposed for morphine. 134 ,135 Morphine is also thought to have a direct effect on the sinoatrial (SA) node136.139 and to depress atrioventricular (AV) conduction. 139 It is likely that fentanyl has a similar action. The latter properties may play a role in the antidysrhythmic actions of morphinel37.139 and fentanyl. 140, 141 Although theoretically these effects could also lead to the development of re-entry-type dysrhythmias, in practice this rarely occurs. Doses of adrenaline sufficient to induce dysrhythmias in dogs were recently found to be no greater during narcotic-nitrous oxide anaesthesia than during halothane, enflurane, or nitrous oxide anaesthesia. 142 However, the incidence of malignant dysrhythmias (ventricular tachycardia and ventricular fibrillation) was less with narcotics plus nitrous oxide than with most potent inhaled anaesthetics. 142 The most common dysrhythmia, other than bradycardia, noted during narcotic anaesthetic technique is supraventricular tachycardia. 143 Tachycardia usually occurs during or immediately after endotracheal intubation or surgical stimulation. This suggests that inadequate anaesthesia rather than a direct effect of the narcotic is responsible for these abnormalities, SUPPLEMENTS A variety of adjuvant drugs have been used as supplements in combination with opioids. Rationales for this approach include attempts to reduce awareness, control hypertension, and decrease the total dose of opioid to minimise postoperative respiratory depression. Unfortunately, with· few exceptions, supplements in combination with opioids usually resuli in loss of cardiovascular stability.
Nilrous oxide
The most common supplement used with intravenous opioids is nitrous oxide, Nitrous oxide has minimal effects on cardiovascular dynamics when administered by itself in dogs,144 but it can depress myocardial contractility in humans. 145 On the other hand, its use in combination with opioids is associated with significant cardiovascular depression, Table 3 . After administration of morphine (2 mg/kg), McDermott and Stanley l46 found that nitrous oxide produced concentrationdependent decreases in stroke volume, cardiac output, and arterial blood pressure and increases in systemic vascular resistance (Table  3 ). These have been consistent findings in humans and animals with all opioids studied, including morphine 24 ,86,88,146 and fentanyl. 27, 124, 147, 148 Myocardial ischaemia may occur as coronary flow decreases from hypotension and coronary vascular resistance increases. 148 While fentanyl alone produces no ventricular dysfunction in the presence of significant coronary artery stenosis, the addition of nitrous oxide can yield significant cardiovascular depression. 27 The mechanism(s) producing cardiovascular depression when nitrous oxide is used along with opioids is unknown but is probably not related to the plasma concentration of the opioid.
Diazepam
Diazepam produces few effects on cardiovascular dynamics when used alone. Unfortunately, the same is not true when it is combined with an opioid, usually for its amnesic properties. In combination with fentanyl, diazepam produces significant cardiovascular depression, including decreases in myocardial contractility, arterial blood 
Other supplements
Cardiovascular depression also occurs when other intravenous supplements are combined with narcotics during anaesthesia. When thiamylal (a barbiturate) is given (4 mg/kg IV) after morphine (l.0 mg/kg IV), cardiac output and stroke volume are decreased 30 to 400,70 and arterial blood pressure by 16%.14 Systemic vascular resistance is increased 35%. Of other intravenous supplements that have been studied, only scopolamine and droperidol do not produce significant myocardial depression or marked changes in cardiovascular dynamics when combined with opioids . 16.27.150 However, droperidol may result in decreased systemic vascular resistance and arterial blood pressure 27 • 150 and increased requirements for crystalloid infusion after opioids. 151 Opioids have also been combined with potent inhaled anaesthetics. Fentanyl and some of the other opioids are often used in low doses during halothane, enflurane, or isoflurane anaesthesia to decrease heart rate, especially after surgical stimulation. 152 Unfortunately, the addition of low to moderate concentrations of halothane after large doses of morphine can produce marked cardiovascular depression in patients with coronary artery disease. 117 Similar results have been found with all but very small doses of fentanyl (~100 JAg) during enflurane anaesthesia.
Neuromuscular relaxants may also alter haemodynamics during opioid-based anaesthesia. For example, after 75 JAg/kg of fentanyl, 0.1 mg/kg of pancuronium usually increases heart rate and cardiac index,153 while d-tubocurarine may cause decreases in arterial blood pressure. 
Neurophysiologic actions
The neurophysiologic state obtained by use of large doses of opioid analgesics is not the same as the 'general anaesthetic' state resulting from inhaled anaesthetics. 154 'General anaesthetics' produce a dose-related generalised depression of the CNS, while opioid analgesics are more selective in action. Perhaps opioids produce anaesthesia by blocking afferent input into the CNS rather than by generalised CNS depression. 154.155 High-dose fentanyl anaesthesia produces a reproducible electroencephalographic (EEG) response characterised by high-voltage slow waves. 154 A similar EEG pattern has been reported after the administration of pethidine, 400 mg. 156 The EEG appearance with fentanyl does not change with the addition of N20 or surgical stimulus and is consistent with surgical anaesthesia. 154 As the anaesthetic effects of a high dose of an opioid decrease, the EEG waves become more frequent and of lower amplitude, suggesting recovery from anaesthesia. 157 However, a strong cause-and-effect relationship between EEG changes and depth of anaesthesia is yet to be established. Increasing dosage with inhaled anaesthetics produces a continuum of EEG changes, resulting in burst suppression and a flat EEG with overdosage. In contrast, a 'ceiling effect' is reached with fentanyl, morphine, sufentanil, and other opioids. Increasing the fentanyl dosage from 50 to 150 JAg/kg does not further effect the EEG (P. S. Sebel and J. G. Bovil, unpublished data).155 Furthermore, the EEG recordings of some patients only slowly return toward 'control' even though plasma and presumably brain concentrations are rapidly decreasing. Despite these problems, recent work by Scott et al. 155 and Smith et al. 157 suggest that computerassisted analysis of the EEG during high-dose fentanyl or other opioid anaesthesia may be of value in determining depth of anaesthesia.
Morphine (1.0 and 3 mg/kg) with 70% N 2 0 causes nonsignificant changes in cerebral blood flow (CBF) and cerebral metabolic rates (CMR) for oxygen, glucose, and lactate in humans.158 Fentanyl, with or without droperidol, results in small decreases in both CMR and CBF. Decreases in CBF are somewhat greater than CMR in dogS. 159 Reductions in CBF may be of benefit in patients with elevated intracranial pressure.
MUSCLE RIGIDITY
Opioids can increase muscle tone, leading to severe rigidity. 160 Problems with muscular rigidity associated with the use of opioids during anaesthesia have been known for years.I60-163 Corrsen et al. l60 reported an 80% incidence of some rigidity in patients receiving droperidol and fentanyl. Grell et al. l64 found that single intravenous doses of fentanyl (0.5 to 0.8 mg) consistently produced chest wall rigidity within 60 to 90 seconds of administration. Since the advent of opioid anaesthetic techniques, the reported incidence of rigidity has varied from 0 to 100%. 40, 63, 98, 103, 160, 162, [164] [165] [166] Opioid-induced rigidity is characterised by increased muscle tone progressing to severe stiffness, particularly in the thoracic and abdominal muscles. Rigidity usually begins just as the patient is losing consciousness; however, it is occasionally present in conscious patients. 92 ,103 Rigidity of the thoracic muscles (wooden chest syndrome), can impair ventilation in the nonparalysed anaesthetised patient. 165 Glottic closure has also been suggested to cause the difficulties with controlled ventilation associated with rigidity. 165 While a well-controlled study evaluating numerous rates of infusion of fentanyl or of any other opioid on the incidence of chest wall (truncal) rigidity has not been performed, rapid or bolus injection increases the severity of rigidity. 98, 103, 167 Rigidity is also more common the older the patient, when dosage is high, and when N 2 0 is used together with narcotic analgesic compounds. 40 ,167-170 Abnormal muscle movements ranging from extremity flexion and/or multiple extremity tonic-clonic movements to global tonic-clonic motions can also occur after the use of opioids. 40 Whether these additional movements are part of a spectrum of neuromuscular activity associated with opioids, represent an 'excitement stage' during opioid anaesthetic induction, or represent subcortical seizure activity is unclear (see the Section Neuroexcitatory Phenomena).
The precise mechanism by which opioids cause muscle rigidity is not clearly understood. Muscle rigidity is not due to a direct action on muscle fibres, since it can be decreased or prevented by pretreatment with muscle relaxants. 40 ,98,171 Also, opioid-induced muscle rigidity is not associated with increases in creatine kinase,168 suggesting that little or no muscle damage occurs during this period. Opioids do not have significant effects on nerve conduction and result in only minimal depression of monosynaptic reflexes associated with muscle stretch receptors. 168 ,170 Opioidinduced rigidity is probably related to the catatonic state which can be induced by all narcotic analgesics. 172 Although some investigators have suggested that opioids produce rigidity by increasing dopamine concentrations within the striatum of the brain,173,174 the mechanism is probably more complex. Rigidity may be the result of stimulation of Il-receptors located on GABAergic interneurons, which can be blocked by lesions in the striatum. Also, striatonigral GABA pathways involved with rigidity can be affected by GABA agonists. [175] [176] [177] Some aspects of opioid-induced catatonia and rigidity (increased incidence with age, extrapyramidal side-effects) are similar to Parkinson's disease and suggest a common neurochemical mechanism.
Rigidity can diminish or preclude adequate ventilation and cause hypercarbia, 98,165 hypoxia, and disturbing cardiovascular changes (e.g. increases in pulmonary vascular resistance). 165 Although succinylcholine will reliably and rapidly terminate rigidity (provided the intravenous infusion is not impaired by a rigid flexed extremity) as well as permit adequate ventilation and mllllmise physiologic perturbations, the unpleasant aesthetics and potential risk of rigidity episodes have motivated the search for prophylactic preventive measures. Pretreatment or concomitant use of nondepolarising muscle relaxants can decrease the incidence and severity of rigidity. 40,98,171 Interestingly, small , doses of diazepam (0.15 mg/kg) have no effect by themselves but potentiate the effects of small (pretreatment) doses of pancuronium (0.022 mg/kg) as an inhibitor of opioid-induced chest wall rigidity. 40 A recent study demonstrated that equipotent doses of metocurine were more effective than pancuronium in both attenuating and abating rigidity, suggesting that AnaeSlhesia and Intensive Care. Vol. /5, No. /, February, 1987 neuromuscular blocking agents that act on prejunctional receptors should be more effective in minimising rigidity than those acting on postjunctional receptors. 171 Thiopentone neither blunts nor terminates opioid-induced rigidity. Chest wall rigidity has also been reported after emergence (during recovery) from anaesthesia. 178 The mechanism for its occurrence may be related to a second peak in plasma fentanyl concentrations or may be due to muscle movements or renewed muscle perfusion after rewarming.
NEUROEXCITATORY PHENOMENA Narcotic analgesics and other anaesthetic agents can cause neuroexcitatory phenomena. 163.173.174.179184 Fentanyl causes EEG seizure activity in cats (20 to 80 /Ag/kg),163 rats (200 to 400 /Ag/kg),172 and dogs (>1250 /Ag/kg). 182 Several investigators have reported grand mal seizure-like motor behaviour in patients gi ven fentanyl. 40.185.186 However, cortical electroencephalography has failed to document epileptic spike waves or any abnormal patterns except for nonelliptoid isolated sharp waves during induction or maintenance of anaesthesia with fentanyl154.187 or sufentanil 188 in spite of high plasma concentrations of the opioids (e.g. 175 ng/ml fentanyl). The spike wave activity has been attributed to subcortical (limbic area) excitation, but whether the waves arise from this area or are of any clinical importance has not been confirmed. Nonetheless, the limbic area is rich in opioid receptors that are probably normally stimulated by endogenous peptides. 47 Other purported mechanisms of opioid associated neuroexci tation and/or seizure activity include disinhibition of pyramidal cells of the hippocampus 188 and increased release of excitatory neurotransmitters, such as met-and leuenkephalin, which possess epileptogenic properties. 180 Although a large clinical and reported experience with fentanyl has documented both its safety and efficacy, concern about the potential for seizures is legitimate. Aside from focal neuroexcitation producing possible local increases in CBF189 and metabolism,190 prolonged seizure activity, even if focal, can lead to neuronal injury and/or cellular death. 181.191.192 No neurologic deficit has yet Anaesthesia and intensive Care, Vol. /5. No. 1, February, 1987 been attributed to the neuroexcitatory effects of opioids.
TECHNIQUES OF HIGH-DOSE OPIOID ANAESTHESIA Morphine
To minimise the risk of hypotension during anaesthesia induction, morphine is often administered slowly over a minimum of 10 to 15 minutes. This is most easily accomplished using a 0.1 ()jo solution of morphine in either dextrose (5 ()jo) or dextrose-saline at a rate of 5 to 10 mg/min with the patient breathing 100% oxygen or oxygen plus N20 until a satisfactory level of anaesthesia is achieved. 24-26.28.193 The incidence of hypotension during induction may also be minimised by concurrent administration of a rapid infusion of intranvenous fluids,26 by placing the patient in a modified Trendelenburg position 26 and/or by pretreatment with histamine (HI and H2) receptor blockers. 193 Induction of anaesthesia usually requires 1 to 3 mg/kg of morphine,23,24,26,28,106 depending on the patient's clinical condition but may require larger amo~nts, especially in patients who have reasonable cardiac reserve. 26 Since significant respiratory depression will occur before loss of consciousness in most patients, ventilatory assistance and then controlled ventilation are usually required. Often sedative-hypnotic compounds are added before or during administration of morphine to reduce opioid dosage and ensure amnesia. 28 Once unconsciousness has been achieved, a muscle relaxant is given, the trachea is intubated, and ventilation continued with either oxygen, an air-oxygen mixture, or nitrous oxide in oxygen. 23 . 24 Careful observation of the patient's response to laryngoscopy and intubation can provide useful information as to the adequacy of anaesthesia. Increases in arterial blood pressure and heart rate, muscle or eyelid movement, and furrowing of the forehead all suggest an inadequate depth of anaesthesia and are indications for additional morphine and/or intravenous or inhalational anaesthetic supplementation before surgery commences. Likewise, reactions to surgical stimuli can usually be treated by similar therapies or, if the patient is considered to be adequately anaesthetised, with an intravenous (nitroglycerin or sodium nitroprusside) or inhalation (low concentrations of enflurane or isoflurane) vasodilator. 16 Fentanyl Similar infusion techniques have been used by many clinicians and investigators to achieve anaesthesia with fentanyl. 2, 60, 171, 186, [194] [195] [196] [197] Induction of anaesthesia via slow infusion of fentanyl, in contrast to infusion of morphine, is usually begun after a small dose of non depolarising muscle relaxant (pancuronium, 1 to 1.S mg; d-tubocurarine, 3 to 4.S mg; or metocurine, 1.0 to 3.S mg) to minimise or prevent muscle rigidity. Infusion rates of fentanyl have generally ranged from 200 to 400 JAg/min, but the rationale for, and techniques of, preoperative patient preparation, premedication, anaesthetic supplementation during induction and maintenance periods, determination of unconsciousness (anaesthesia), use of muscle relaxants and doses of fentanyl for endotracheal intubation, the remainder of the operation, and total doses of fentanyl have varied enormously. 2, 7, 27, 34, 108, 171 Many of these differences may be attributed to the debate as to whether fentanyl should be considered an anaesthetic. 7 ,34,194,195 Similar qnestions are, as yet, incompletely answered, and it is likely that the debates and enormous variety of methods of using fentanyl for complete anaesthesia or as an analgesic supplement will continue. Some clinicians believe it is quicker, easier, and more efficacious to infuse a single large, precalculated bolus of fentanyl (SO to 100 JAg/kg), usually with a large dose of pancuronium (0.1 to 0.12 mg/kg, to minimise fentanyl-induced bradycardia), for both induction and maintenance of anaesthesia. [48] [49] [50] 64, 96, 98, 109, 196, 197 Following this approach, ventilation is controlled, the trachea is intubated and, within moments, the patient is ready for surgical preparation. V~riations on the bolus technique are as numerous as on the slower infusion approach of using fentanyl, undoubtedly for the same reasons.
HORMONAL RESPONSES WITH OPIOID ANAESTHESIA
Considerable interest has been expressed in recent years in possible anaesthetic modification of the hormonal and associated metabolic responses to surgical trauma. The so-called surgical 'stress response' consists of increases in plasma concentrations of the catecholamines, cortisol, ADH, human growth hormone, glucose, lactate, pyruvate, and sometimes other hormones and metabolites. Plasma concentrations of the stress hormones increase during general anaesthesia with most inhalational and intravenous agents and are further increased with operation. 61, 198, 199 Surgically induced increases in most stress hormones are related to the severity of the operative trauma,198 being much greater during intra-abdominal surgery than during body surface procedures. 199, 200 These increased levels of stress hormones are considered undesirable because they promote haemodynamic instability and intraoperative and postoperative metabolic catabolism. Morphine Analysis of hormonal data from a number of studies suggests that morphine modifies hormonal responses to surgical trauma in a dose-related fashion.2oo-206 Morphine, even in small doses, inhibits the release of ACTH and blocks at least part of the pituitary-adrenal response to surgical stress. 202 After morphine (0.33 mg/kg) anaesthesia, significant decreases in blood lactate occur; however, pyruvate concentrations remain unchanged. 203 Morphine (1.0 mg/kg) anaesthesia suppresses surgically induced increases in plasma cortisol, but not human growth hormone, during major abdominal operations. 204 During cardiac surgery with morphine (4 mg/kg) anaesthesia, plasma concentrations of both cortisol and human growth hormone are not increased in the pre-bypass period but are increased during bypass. [204] [205] [206] Increases in plasma conc.entrations of these hormones continue after bypass as well as postoperatively. 205 Morphine has also been shown to increase some stress-response hormones. 206 and/or vasodilation). Increases in plasma catecholamine concentrations appear to be responsible for the positive inotropic effect of morphine in dogs, since they are blocked by (3-adrenergic blocking drugs or previous surgical adrenalectomy. 56 Morphine can also increase concentrations of catecholamines in both blood and urine in humans. 57 . 59 Secretion of catecholamines in humans may be related to inadequate analgesia (anaesthesia) but may also be dependent on the functional state of the sympathetic nervous system and the plasma concentration of morphine. For example, patients with hypertension and other evidence of increased sympathetic activity and patients with low morphine blood levels have higher urine noradrenaline excretion rates than those of similar normotensive patients or those with high morphine blood levels. 5 7.58 There is also evidence that the change in plasma noradrenaline concentration with anaesthetic induction with morphine is related to preinduction plasma noradrenaline concentrations; patients with low preoperative plasma noradrenaline concentrations experience a small rise in these amines, whereas patients with higher preoperative plasma noradrenaline concentrations experience no change or decreases in these concentrations after anaesthetic induction. 57 . 58 Similar changes are also observed after induction of anaesthesia with inhalational agents. 2lO
Although morphine is known to stimulate ADH secretion in dogs and rats,211,212 it does not appear to do so in the absence of surgical stimulus in humans.213 Plasma ADH rises significantly during morphine (1.0 mg/kg) plus nitrous oxide anaesthesia in humans during surgery before cardiopulmonary bypass and increases further during bypass,213 Plasma renin activity also increases markedly in patients anaesthetised with morphine (1 to 3 mg/kg) and nitrous oxide during cardiac surgery.107 Increases in plasma renin are frequently but not always correlated with simultaneous increases in arterial pressure in these patients. 107
Fentanyl
Fentanyl and some of its newer congeners seem to be even more effective than morphine in modifying hormonal responses to surgery. In a study of healthy women undergoing prolonged gynaecologic surgery, anaesthesia Anaesthesia and Inrensive Care, Vol. 15, No. I. February, 1987 with nitrous oxide supplemented with fentanyl (50 f.lg/kg) was compared with halothane and nitrous oxide. 214 Fentanyl abolished the hyperglycemic response to surgery and reduced cortisol and growth hormone responses as compared with halothane. Similar results have also been reported with large doses of fentanyl in patients undergoing gastric surgery. 215 The catecholamine response to induction of anaesthesia with fentanyl infusion in patients about to undergo coronary artery surgery was recently investigated. 62 Plasma noradrenaline levels were significantly elevated after fentanyl, 15 f.lg/kg, was administered (probably secondary to inadequate analgesia) and remained elevated after 30 f.lg/kg but returned to control values after 50 f.lg/kg. No significant changes occurred in plasma adrenaline or dopamine. Other investigations have found that fentanyl in doses of ~ 50 f.lg/kg prevents increases in plasma catecholamine concentrations during cardiac surgerY,61,113,216 although marked increases have occurred during cardiopulmonary bypass. 61 ,113 Marked increases in catecholamine concentrations measured during cardiopulmonary bypass that are not blocked by maintaining plasma concentrations close to prebypass levels l13 or by increasing these concentrations above prebypass levels (T. H. Stanley, unpublished data) are presumably a response to the significant abnormal physiologic state during this period (i.e. haemodilution, hypothermia, and nonpulsatile flow). Indeed, there is some evidence that vasopressin and catecholamine responses to cardiopulmonary bypass can be significantly attenuated by the use of pulsatile flOW,217 although this has not been confirmed by all investigators. 218 Anaesthesia with fentanyl, 60 to 100 f.lg/kg, prevents rises in plasma ADH, renin, and aldosterone during the period before cardiopulmonary bypass. 3 . 216 This is in contrast to the significant increases of these hormones observed in similar patients anaesthetised with morphine.213 However, during bypass, plasma ADH rises significantly in spite of high doses (100 f.lg/kg) of fentanyl. 3 High-dose fentanyl anaesthesia usually prevents increases in blood glucose, plasma cortisol, and plasma growth hormone concentrations in most patients throughout open-heart operations. 61 ,113,216,219 However, this reduction in the stress response is not consistently found in all patients, especially during and after cardiopulmonary bypass and during the postoperative period, even when fentanyl administration is continued for 12 to 18 hours after surgery. 219 In summary, fentanyl appears to be somewhat more effective than morphine in reducing the endocrine and metabolic responses to surgery. Although this may be due to pharmacologic differences between the drugs, it may also be the result of differences in potency (as sufentanil, which is 5 to 10 times as potent as fentanyl, appears more effective as a inhibitor of stress hormonal responses than the latter),220 increased dosage,61,216,217 anaesthetic technique,61 or increased speed of onset of action (as has been suggested with alfentanil in clinical studies 133 and with carfentanil in investigations with wild animals). 128 The effects of other opioids on the stress response to surgery have received little attention. Papaverine (extract of opium) is significantly less effective than fentanyl in attenuating the changes associated with cardiac surgery, 219 However, the new narcotics, alfentanil and sufentanil, seem to be more effective than fentanyl in cardiac and noncardiac operations,120,220 although only a few carefully controlled clinical studies have been completed. 120
MECHANISM OF INHIBITION OF THE STRESS RESPONSE
The mechanism by which large doses of opioids inhibit the stress response to surgical trauma is unknown. Whatever the mechanism, it probably involves pituitary release of ACTH and perhaps other stress hormone precursors, as ACTH secretion is reduced by high doses of opioids. It is interesting that decreases in plasma human growth hormone concentrations produced by morphine (4 gm/kg) are totally reversible after ACTH administration. 206 It is known that the endogenous opioid-like peptides play an important regulatory role in the secretion of several pituitary hormones, 2~1 possibly via alteration in the release of neurotransmitters (e.g. dopamine) that regulate secretion of pituitary hormone-releasing or release-inhibiting factors. 222 ,223 Perhaps exogenous opiates have similar inhibiting or stimulating actions.
Thus, techniques of opioid analgesia, particularly techniques of high-dose fentanyl anaesthesia, diminish the hormonal 'stress' response to surgery. This metabolic response is appropriate when 'fight or flight' is required, for it ensures an increase in metabolism and energy availability necessary for the increased work associated with these states. However, such responses may be totally inappropriate in patients undergoing some forms of cardiovascular surgery, such as patients with coronary artery disease undergoing coronary artery bypass grafting. Increase in plasma catecholamine concentrations in these patients will lead to increased myocardial work and may further compromise an already damaged myocardium. Elevated plasma levels of the stress hormones in the period after surgery increase protein catabolism and may delay recovery. I f these metabolic responses are modified, morbidity and mortality should be reduced. However, there is as yet no evidence to support this theoretical benefit. 'Stress-free anaesthesia' is at best an attractive biochemical concept. Whether it is of clinical benefit is uncertain. Certainly any reduction in the metabolic responses to anaesthesia and surgery is short lived. 113, 215, 219 With morphine, at least, there is no improvement in postoperative nitrogen balance. 205 Whether the same is true following high doses of fentanyl or the newer synthetic opioids remains to be documented.
